According to a report published by Grand View Research, Inc.; the global stem cells market is expected to accomplish a valuation of around USD 15.63 billion by 2025.
Increasing scope of these cells in clinical applications can propel the market during the forecast period (2014 to 2025). Researchers are taking more efforts to develop human stem cells. Increasing development of these cells for study of disease management is anticipated to increase the production of regenerative medicine, which will boost the market in the coming years.
Technological innovations in this field such as continuous supply of induced pluripotent stem cells (iPSCs) and growing efforts for regeneration of diseased or dying cells are also expected to accelerate the market growth. additionally, funding from government as well as private organization is also expected to fuel the market growth.
Full Research Report On Stem Cells Market Analysis:
www.grandviewresearch.com/industry-analysis/stem-cells-market
UK stem cells market share, by technology, 2014 - 2025 (USD Million)
Worldwide stem cells market can be segmented on the basis of product, application, technology, therapy, and region. Based on product, the market can be bifurcated into induced pluripotent stem cells, adult stem cells, human embryonic stem cells, and very small embryonic like stem cells. The adult stem cells segment is anticipated to lead the market during the forecast period. Factors including no ethical issues related to their use, long term renewal property, and lesser rejection rate are driving the segment growth. Also, research activities related to organoid generation and drug screening are considered as crucial factors for the segment growth.
As per application, the market can be categorized into regenerative medicine and drug discovery and development. The regenerative medicine segment is further classified into neurology, orthopedics, oncology, hematology, cardiovascular and myocardial infraction, injuries, diabetes, liver disorders, and incontinence, among others.
Regenerative medicine is anticipated to hold a significant market share over the forecast period due to existence of numerous pipeline projects. These medicines can cure traumatic injuries and degenerative diseases. Neurology segment is anticipated to hold major market share in terms of revenue owing to availability of the Food and Drug Administration (FDA) approved products. Oncology segment is expected to grow on account of presence of strong pipeline medicines for cancer therapies.
Browse More Reports Of This Category By Grand View Research At:
www.grandviewresearch.com/industry/biotechnology
Global stem cell market, by region, 2016 (%)
Based on technology, the stem cells market is classified into cell acquisition, cryopreservation, cell production, and expansion and sub-culture. Cell acquisition is further categorized into bone marrow harvest, umbilical blood cord, and apheresis. The segment is anticipated to occupy the largest market share throughout the forecast period owing to their growing importance in cell harvesting. Development of new cells using bone marrow is quicker therefore, it is the most preferred technology. The cell production segment held substantial market share in the past due to constant technological advancements to meet the ever-increasing demand from clinical applications.
As per therapy, the market is split into autologous and allogeneic stem cell therapy. In terms of revenue, the autologous stem cell therapy segment led the market in 2016 due to high acceptance of these products. Moreover, high compatibility of these cells is anticipated to further propel the uptake over the forecast period.
Geographically, the market can be divided into Europe, North America, Asia Pacific, Latin America, and Middle East and Africa. North America is anticipated to account for a large market share over the forecast period. Increasing R&D activities coupled with funding for advanced cellular therapy is projected to bode well for the regional market expansion. Asia Pacific is projected to showcase momentous growth over the forecast period. Ongoing R&D projects in countries such as Singapore, Australia, and Japan are projected impel the regional expansion.
Enhanced commercialization opportunities are likely to further boost the market growth. Also, updated regulatory framework related to regenerative medicine in Japan is projected to create business opportunities in near future. North America holds the large share of the market. This is credited to extensive R&D efforts and huge funding for advance cellular research in the U.S.
Some of the leading companies operating in the stem cells market include Cellular Engineering Technologies Inc.; BrainStorm Cell Therapeutics; Bioheart Inc.; Advanced Cell Technology Inc.; and PromoCell GmbH.
Grand View Research has segmented the global stem cells market on the basis of product, application, technology, therapy, and region:
Stem Cell Product Outlook (Revenue, USD Billion, 2014 - 2025)
-
Adult Stem Cells
-
Neuronal Stem Cells
-
Hematopoietic Stem Cells
-
Mesenchymal Stem Cells
-
Umbilical Cord Stem Cells
-
Others
-
-
Human Embryonic Stem Cells
-
Induced Pluripotent Stem Cells
-
Very Small Embryonic Like Stem Cells
Stem Cell Application Outlook (Revenue, USD Billion, 2014 - 2025)
-
Regenerative Medicine
-
Neurology
-
Orthopedics
-
Oncology
-
Hematology
-
Cardiovascular and Myocardial Infraction
-
Injuries
-
Diabetes
-
Liver Disorder
-
Incontinence
-
Others
-
-
Drug Discovery and Development
Stem Cell Technology Outlook (Revenue, USD Billion, 2014 - 2025)
-
Cell Acquisition
-
Bone Marrow Harvest
-
Umbilical Blood Cord
-
Apheresis
-
-
Cell Production
-
Therapeutic Cloning
-
In-vitro Fertilization
-
Cell Culture
-
Isolation
-
-
Cryopreservation
-
Expansion and Sub-Culture
Stem Cell Therapy Outlook (Revenue, USD Billion, 2014 - 2025)
-
Autologous Stem Cell Therapy
-
Allogeneic Stem Cell Therapy
Stem Cell Regional Outlook (Revenue, USD Billion, 2014 - 2025)
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email:Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/stem-cells-market
